Ashland reports higher sales and profit in fiscal Q3
Ashland posted fiscal Q3 sales of $497 million, up 7% year over year; income from continuing operations was $41 million, or $0.89 a share.
Net income was $16 million, or $0.35 a share, swinging to profit from a year-earlier loss.
Non-GAAP adjusted EBITDA fell 4% to $109 million, on lower Specialty Additives and Intermediates earnings.
Operating cash flow rose to $121 million; non-GAAP ongoing free cash flow eased to $103 million.
Ashland reaffirmed its fiscal 2026 sales outlook of $1.84 billion-$1.87 billion, keeping non-GAAP adjusted EBITDA guidance at $385 million-$400 million.